Xuelin Li

University of South Carolina - Darla Moore School of Business

1014 Greene Street

Columbia, SC 29208

United States

SCHOLARLY PAPERS

11

DOWNLOADS
Rank 31,381

SSRN RANKINGS

Top 31,381

in Total Papers Downloads

1,950

SSRN CITATIONS

1

CROSSREF CITATIONS

2

Scholarly Papers (11)

1.

Common Ownership and Innovation Efficiency

Jacobs Levy Equity Management Center for Quantitative Financial Research Paper
Number of pages: 60 Posted: 27 Nov 2019 Last Revised: 13 Jul 2021
Xuelin Li, Tong Liu and Lucian A. Taylor
University of South Carolina - Darla Moore School of Business, University of Pennsylvania - Finance Department and University of Pennsylvania - The Wharton School
Downloads 829 (36,608)
Citation 1

Abstract:

Loading...

venture capital, common ownership, competition, healthcare

2.

The Race of Unicorns: A Signaling Story of Private Acquisitions

Number of pages: 69 Posted: 02 Jul 2018 Last Revised: 16 Sep 2019
Xuelin Li
University of South Carolina - Darla Moore School of Business
Downloads 238 (160,631)

Abstract:

Loading...

Real Options, Startups, Merger and Acquisitions, Initial Public Offering, Information Asymmetry

3.

Pivots and Prestige: Venture Capital Contracts with Experimentation

Number of pages: 71 Posted: 18 Nov 2019 Last Revised: 16 Feb 2021
Xuelin Li and Martin Szydlowski
University of South Carolina - Darla Moore School of Business and University of Minnesota - Twin Cities - Carlson School of Management
Downloads 199 (191,120)

Abstract:

Loading...

Venture Capital, Experimentation, Signaling, Pivots, Prestige Projects

4.

Find and Replace: R&D Investment Following the Erosion of Existing Products

Harvard Business School Entrepreneurial Management Working Paper No. 19-058
Number of pages: 59 Posted: 17 Sep 2018 Last Revised: 10 Sep 2021
Harvard University - Business School (HBS), University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 185 (202,987)
Citation 2

Abstract:

Loading...

R&D Investments, Drug Development, Product Shocks, M&A, Biopharmaceutical Industry, FDA

5.

Healthcare across Boundaries: Urban-Rural Differences in the Financial and Healthcare Consequences of Telehealth Adoption

Boston University Questrom School of Business Research Paper No. 3807577
Number of pages: 46 Posted: 19 Mar 2021 Last Revised: 22 Jul 2021
Meizi Zhou, Xuelin Li and Gordon Burtch
University of Minnesota - Twin Cities - Carlson School of Management, University of South Carolina - Darla Moore School of Business and Boston University - Questrom School of Business
Downloads 154 (238,659)

Abstract:

Loading...

Telehealth, Physician Licensure, Medicare Payment, Hospitals, Healthcare Qualities, Telemedicine

6.

Virtual Competition and Cost of Capital: Evidence from Telehealth

Number of pages: 75 Posted: 26 Apr 2021 Last Revised: 06 Aug 2021
Kimberly Cornaggia, Xuelin Li and Zihan Ye
Pennsylvania State University - Department of Finance, University of South Carolina - Darla Moore School of Business and University of Nevada, Las Vegas
Downloads 103 (320,261)

Abstract:

Loading...

telehealth, municipal bond, healthcare finance, healthcare inequality, bankruptcy

7.

Secret Scouting

Number of pages: 43 Posted: 17 Sep 2019
Xuelin Li and Fangyuan Yu
University of South Carolina - Darla Moore School of Business and University of Minnesota
Downloads 92 (344,359)

Abstract:

Loading...

Preemption, Venture Capital, Search, Disclosure

Paying off the Competition: Market Power and Innovation Incentives

Number of pages: 60 Posted: 30 Jun 2021 Last Revised: 06 Aug 2021
University of South Carolina - Darla Moore School of Business, Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering and University of Minnesota - Carlson School of Management
Downloads 79 (381,605)

Abstract:

Loading...

Drug Development, Pharmaceutical Industry, Monopoly, Antitrust, Market Power, Competition, Innovation

Paying Off the Competition: Market Power and Innovation Incentives

NBER Working Paper No. w28964
Number of pages: 60 Posted: 28 Jun 2021 Last Revised: 20 Jul 2021
University of South Carolina - Darla Moore School of Business, Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering and University of Minnesota - Carlson School of Management
Downloads 3 (800,209)
  • Add to Cart

Abstract:

Loading...

Merchants of Death: The Effect of Credit Supply Shocks on Hospital Outcomes

Number of pages: 55 Posted: 19 Apr 2021
University of Minnesota - Twin Cities, University of Minnesota - Twin Cities - School of Public Health, University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 52 (475,035)

Abstract:

Loading...

Healthcare finance, hospitals, banks, credit supply, lending, health outcomes, stress test

Merchants of Death: The Effect of Credit Supply Shocks on Hospital Outcomes

NBER Working Paper No. w28709
Number of pages: 56 Posted: 26 Apr 2021 Last Revised: 20 Jul 2021
University of Minnesota - Twin Cities, University of Minnesota - Twin Cities - School of Public Health, University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 1 (824,297)
  • Add to Cart

Abstract:

Loading...

10.

Hype Cycles: Dynamic Information Design with Two Audiences

Number of pages: 69 Posted: 16 Sep 2021
University of South Carolina - Darla Moore School of Business, University of Minnesota - Twin Cities - Carlson School of Management and University of Minnesota
Downloads 15 (673,323)

Abstract:

Loading...

Dynamic information design, Bayesian persuasion, multiple receivers, entry games, real options, complementarities

11.

Find and Replace: R&D Investment Following the Erosion of Existing Products

Management Science, forthcoming
Number of pages: 59
Harvard University - Business School (HBS), University of South Carolina - Darla Moore School of Business and University of Minnesota - Carlson School of Management
Downloads 0

Abstract:

Loading...

R&D Investments, Drug Development, Product Shocks, M&A, Biopharmaceutical Industry, FDA